DR Reddys Laboratories Ltd

RDY Biotech & pharma

Develops generic medicines for various diseases and conditions.

Mar 2025Revenue $3.81B/yrExpenses $2.97B/yr
No trend
Figures by year

Is DR Reddys Laboratories profitable?

Yes. In the 12 months to Mar 2025, revenue was $3.81B and expenses $2.97B.

Fiscal year toRevenueExpensesOperating profit
Mar 2025$3.81B$2.97B$842M
Mar 2024$3.35B$2.54B$813M
Mar 2023$2.99B$2.30B$695M
Mar 2022$2.83B$2.44B$389M
Mar 2021$2.59B$2.26B$332M
Mar 2020$2.32B$2.10B$212M
Mar 2019$2.23B$1.92B$302M
Mar 2018$2.18B$2.00B$183M